Duffy Sean P. 4

What Happened Sean P. Duffy, CEO of Omada Health, was granted 323,529 restricted stock units (RSUs) on 2026-03-05. The award is reported as an acquisition (code A) at $0.00 per share—no cash was paid at grant; the economic value will depend on Omada’s future stock price when RSUs vest. This is an equity compensation award rather than an open-market purchase or sale.

Key Details

• Transaction date and price: 2026-03-05; 323,529 RSUs granted at $0.00 per share (Form 4 filed 2026-03-13).
• Vesting: 1/16th of the RSUs vest on each quarterly anniversary beginning March 1, 2026; fully vested after four years (see footnote F1).
• Shares owned after transaction: the filing’s reported beneficial ownership (Column 5) is updated as of the filing date and incorporates transactions from a Form 4 filed 3/11/2026 (see footnote F2).
• Additional note: some shares are held in family trusts for the benefit of the reporting person’s family; Mr. Duffy disclaims beneficial ownership of those trust-held shares except to the extent of any pecuniary interest (footnote F3).
• Filing timeliness: the Form 4 was filed on 2026-03-13 for a 2026-03-05 grant (filed 8 days after the transaction), which is later than the typical two-business-day reporting deadline.

Context RSU grants are a common form of executive compensation and do not involve an immediate purchase or sale of shares—value is realized only as RSUs vest and convert into common stock. Because this was an award (not a market buy or sale), it’s primarily a compensation event rather than a direct market sentiment signal.